AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Tuesday reported a loss of $10.4 million in its first quarter.
On a per-share basis, the Austin, Texas-based company said it had a loss of $1.29.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.21 per share.
The biopharmaceutical company posted revenue of $165,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LUMO at https://www.zacks.com/ap/LUMO
